Pdx Pharmaceuticals
About:
Pdx Pharmaceuticals develop novel combination and immunotherapies to treat cancer.
Website: http://www.pdxpharm.com/
Twitter/X: pdxpharm
Top Investors: Kuni Foundation
Description:
Pdx Pharmaceuticals is a biopharmaceutical company. They provide common biological pathways to achieve synergistic clinical benefit. Their therapeutic candidates bridge the innate and adaptive immune systems by generating profound CD8+ T cell production.
Total Funding Amount:
$1.55M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Portland, Oregon, United States
Founded Date:
2010-01-01
Founders:
Wassana Yantasee
Number of Employees:
11-50
Last Funding Date:
2019-11-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai